Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
Safely Scaling Highly Potent API manufacturing
Ever more drug developers are searching for CDMOs with contamination-limiting capabilities. But how can they know which have these high-potency credentials? read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Scinai Appoints Head of Supply Chain and Business Process Administration
Monday, August 10, 2026
Scinai Immunotherapeutics announced that its wholly owned subsidiary, Scinai Biopharma Services, has appointed Mr. Eran Kuratz as Head of Supply Chain... read more
Altasciences Expands Harleysville R&D Lab to Strengthen Early-Stage CDMO Services
Thursday, August 06, 2026
Altasciences has completed an expansion of the research and development laboratory at its drug product formulation and manufacturing facility in ... read more
Clinilabs Names Dagher CMO, Siddiqui Principal Investigator
Wednesday, August 05, 2026
Clinilabs has appointed Bob Dagher, M.D., as chief medical officer and Waqar Ahmed Siddiqui, M.D., as principal investigator at its Eatontown, New ... read more
Porton Advanced Wins Class C License to Expand CGT Manufacturing Into Commercial Stage
Wednesday, August 05, 2026
Porton Advanced Solutions has secured a Drug Manufacturing License (Class C) from China’s National Medical Products Administration, a milestone that ... read more
Altruist Biologics Completes First Commercial PPQ at Hangzhou Site
Wednesday, August 05, 2026
Altruist Biologics has completed the first commercial process performance qualification campaign for its 20,000L stainless steel bioreactors at its ... read more